Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
GRI Bio (GRI)
NASDAQ:GRI
Holding GRI?
Track your performance easily
GRI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.30 - $65.00
Previous Close$0.74
Volume234.64K
Average Volume (3M)4.43M
Market Cap
$6.61M
Enterprise Value$2.00M
Total Cash (Recent Filing)$4.75M
Total Debt (Recent Filing)$131.00K
Price to Earnings (P/E)―
Beta-1.09
Next Earnings
Aug 14, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-51.88
Shares Outstanding8,933,366
10 Day Avg. Volume442,596
30 Day Avg. Volume4,430,126
Standard Deviation2.76
R-Squared0.00059
Alpha0.30
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)1.80
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.17
Forecast
1Y Price Target
$11.00Price Target Upside1386.49% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
GRI Bio News
Ownership Overview
―
Insiders
<0.01% Mutual Funds
0.56% Other Institutional Investors
99.43% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
GRI FAQ
What was GRI Bio’s price range in the past 12 months?
GRI Bio lowest stock price was $0.30 and its highest was $65.00 in the past 12 months.
What is GRI Bio’s market cap?
Currently, no data Available
When is GRI Bio’s upcoming earnings report date?
GRI Bio’s upcoming earnings report date is Aug 14, 2024 which is 131 days ago.
How were GRI Bio’s earnings last quarter?
Currently, no data Available
Is GRI Bio overvalued?
According to Wall Street analysts GRI Bio’s price is currently Undervalued.
Does GRI Bio pay dividends?
GRI Bio does not currently pay dividends.
What is GRI Bio’s EPS estimate?
GRI Bio’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GRI Bio have?
GRI Bio has 8,933,366 shares outstanding.
What happened to GRI Bio’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of GRI Bio?
Currently, no hedge funds are holding shares in GRI
---
GRI Bio Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.00 (1386.49% Upside)
$11.00 (1386.49% Upside)
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.0%
Last 30 Days ▲ 3.2%
Last 30 Days ▲ 3.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-97.99%
12-Months-Change
Fundamentals
Return on Equity
-280.75%
Trailing 12-Months
Asset Growth
23.96%
Trailing 12-Months
Company Description
GRI Bio
Vallon Pharmaceuticals Inc is a biopharmaceutical company primarily focused on the development and commercialization of proprietary biopharmaceutical products. The company develops prescription drugs for central nervous system disorders. Its product ADAIR, a proprietary, abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder, and narcolepsy.
---
GRI Stock 12 Month Forecast
Average Price Target
$11.00
▲(1386.49% Upside)
Technical Analysis
Best Analysts Covering GRI
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+87.80%
initiated a buy rating 3 months ago
Copying Edward Woo's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +87.80% per trade.
---